Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-09

FDA Approved: ASCOMP WITH CODEINE — Supplemental Application (LGM PHARMA SOLUTIONS, LLC)

View source ↗

Summary

The FDA approved a supplemental application for ASCOMP WITH CODEINE, a combination product of butalbital, aspirin, caffeine, and codeine phosphate, manufactured…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASCOMP WITH CODEINE (Butalbital, aspirin (acetylsalicylic acid), caffeine, and codeine phosphate)

Snippet

SUPPL AP for ASCOMP WITH CODEINE (BUTALBITAL, ASPIRIN, CAFEINE, AND CODEINE PHOSPHATE)